Prevacid

TAP Pharmaceuticals Inc. (TAP) is a leading pharmaceutical company that has enjoyed a presence in the marketplace since 1985. Today, with net sales of over $4 billion, it promotes some of the best-selling products in various therapeutic classes.

Today’s eDetailing offerings are moving towards commodity status, a trend that conflicts with the challenge inherent in the process of marketing pharmaceuticals to a physician population that varies according to factors including age and medical specialty. Therefore, closerlook introduced a proprietary, client-branded, integrated program that distinguished it from the traditional eDetailing model. This program includes an on- and off-line acquisition strategy, database management, flexible and extensible architecture, and ongoing support and maintenance.